Soree Ryang
Busan, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Predicting 10-Year Diabetes Risk Through Physiological Acceleration: A Longitudinal Deep Learning Ensemble Approach.
Journal: Diagnostics (Basel, Switzerland)
Published: February 24, 2026
A novel disposition index without insulin is an earlier and sensitive predictor of type 2 diabetes than current diagnostic criteria.
Journal: Diabetes research and clinical practice
Published: November 28, 2025
Declining insulin sensitivity is a key pathological contributor to dysglycemia: a longitudinal validation study in the Korean genome and epidemiology study.
Journal: Frontiers in endocrinology
Published: October 15, 2025
High one-hour plasma glucose is an intermediate risk state and an early predictor of type 2 diabetes in a longitudinal Korean cohort.
Journal: Diabetes research and clinical practice
Published: September 23, 2024
Association of the Preoperative Controlling Nutritional Status (CONUT) Score with Clinicopathological Characteristics in Patients with Papillary Thyroid Carcinoma.
Journal: Endocrinology and metabolism (Seoul, Korea)
Published: April 09, 2024
Author Correction: Association between visceral adipose tissue volume, measured using computed tomography, and cardio-metabolic risk factors.
Journal: Scientific reports
Published: August 07, 2023
Trabecular Bone Score and Central Quantitative Computed Tomography for the Prediction of Vertebral Fragility Fractures in Postmenopausal Women.
Journal: Journal of bone metabolism
Published: December 29, 2022
Heart Failure and Stroke Risks in Users of Liothyronine With or Without Levothyroxine Compared with Levothyroxine Alone: A Propensity Score-Matched Analysis.
Journal: Thyroid : official journal of the American Thyroid Association
Published: May 16, 2022
A double-blind, Randomized controlled trial on glucose-lowering EFfects and safety of adding 0.25 or 0.5 mg lobeglitazone in type 2 diabetes patients with INadequate control on metformin and dipeptidyl peptidase-4 inhibitor therapy: REFIND study.
Journal: Diabetes, obesity & metabolism
Published: February 23, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026